Clinical Trial Update: Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART) [Phase 3]

View source ↗

Summary

A Phase 3 trial (SMART) evaluating motexafin gadolinium with radiation therapy for brain neoplasms and non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasms
• Non-small Cell Lung Cancer

Drugs mentioned

• Motexafin Gadolinium (motexafin gadolinium)

Snippet

Sponsor: Pharmacyclics LLC. | Conditions: Brain Neoplasms, Carcinoma, Non-Small-Cell Lung | Phase 3 | Status: COMPLETED